[1]
|
Sung, H., Ferlay, J., Siegel, R.L., Laversanne, M., Soerjomataram, I., Jemal, A. and Bray, F. (2021) Global Cancer Sta-tistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71, 209-249. https://doi.org/10.3322/caac.21660
|
[2]
|
Kimura, T. and Egawa, S. (2018) Epidemiology of Prostate Cancer in Asian Countries. International Journal of Urology: Official Journal of the Japanese Urological Association, 25, 524-531. https://doi.org/10.1111/iju.13593
|
[3]
|
Ntatsis, K., Papantoni, E., Kyziridis, D., Kalakonas, A., Hristakis, C., Tzavara, C. and Tentes, A.A. (2021) Ovarian Cancer: 20-Year Experience with Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy. Journal of BUON, 26, 1754-1761.
|
[4]
|
Brand, A.H., DiSilvestro, P.A., Sehouli, J. and Berek, J.S. (2017) Cytoreductive Surgery for Ovarian Cancer: Quality Assessment. Annals of Oncology, 28, viii25-viii29. https://doi.org/10.1093/annonc/mdx448
|
[5]
|
Méjean, A., Ravaud, A., Thezenas, S., et al. (2021) Sunitinib Alone or after Nephrectomy for Patients with Metastatic Renal Cell Carcinoma: Is There Still a Role for Cytoreductive Ne-phrectomy? European Urology, 80, 417-424.
https://doi.org/10.1016/j.eururo.2021.06.009
|
[6]
|
Ljunggren, M., Nordenvall, C. and Palmer, G. (2021) Direct Surgery with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Patients with Colorectal Per-itoneal Metastases. European Journal of Surgical Oncology, 47, 2865-2872. https://doi.org/10.1016/j.ejso.2021.05.046
|
[7]
|
Yin, J.J., Pollock, C.B. and Kelly, K. (2005) Mechanisms of Cancer Metastasis to the Bone. Cell Research, 15, 57-62.
https://doi.org/10.1038/sj.cr.7290266
|
[8]
|
Kaplan, R.N., Psaila, B. and Lyden, D. (2006) Bone Marrow Cells in the “Pre-Metastatic Niche”: Within Bone and Beyond. Cancer and Metastasis Reviews, 25, 521-529. https://doi.org/10.1007/s10555-006-9036-9
|
[9]
|
Zhang, X. (2019) Interactions between Cancer Cells and Bone Microenvironment Promote Bone Metastasis in Prostate Cancer. Cancer Communications (London), 39, 76. https://doi.org/10.1186/s40880-019-0425-1
|
[10]
|
Clézardin, P., Coleman, R., Puppo, M., et al. (2021) Bone Me-tastasis: Mechanisms, Therapies, and Biomarkers. Physiological Reviews, 101, 797-855. https://doi.org/10.1152/physrev.00012.2019
|
[11]
|
Coletta, A.M., Sayegh, N. and Agarwal, N. (2021) Body Com-position and Metastatic Prostate Cancer Survivorship. Cancer Treatment and Research Communications, 27, Article ID: 100322. https://doi.org/10.1016/j.ctarc.2021.100322
|
[12]
|
Predina, J.D., Kapoor, V., Judy, B.F., et al. (2012) Cytoreduction Surgery Reduces Systemic Myeloid Suppressor Cell Populations and Restores Intratumoral Immuno-therapy Effectiveness. Journal of Hematology & Oncology, 5, 34.
https://doi.org/10.1186/1756-8722-5-34
|
[13]
|
Cai, Z., Chen, W., Zhang, J. and Li, H. (2018) Androgen Receptor: What We Know and What We Expect in Castration-Resistant Prostate Cancer. International Urology and Nephrology, 50, 1753-1764.
https://doi.org/10.1007/s11255-018-1964-0
|
[14]
|
Sow, Y., Sow, O., Fall, B., et al. (2019) Impact of Tumor Cytoreduction in Metastatic Prostate Cancer. Research and Reports in Urology, 11, 137-142. https://doi.org/10.2147/RRU.S204507
|
[15]
|
Heidenreich, A., Fossati, N., Pfister, D., et al. (2018) Cytoreductive Radical Prostatectomy in Men with Prostate Cancer and Skeletal Metastases. European Urology Oncology, 1, 46-53. https://doi.org/10.1016/j.euo.2018.03.002
|
[16]
|
Katelaris, N., Murphy, D., Lawrentschuk, N., Katelaris, A. and Moon, D. (2016) Cytoreductive Surgery for Men with Metastatic Prostate Cancer. Prostate International, 4, 103-106. https://doi.org/10.1016/j.prnil.2015.11.003
|
[17]
|
Culp, S.H., Schellhammer, P.F. and Williams, M.B. (2014) Might Men Diagnosed with Metastatic Prostate Cancer Benefit from Definitive Treatment of the Primary Tumor? A SEER-Based Study. European Urology, 65, 1058-1066.
https://doi.org/10.1016/j.eururo.2013.11.012
|
[18]
|
Cheng, B., Ye, S. and Bai, P. (2021) The Efficacy of Cytoreductive Surgery for Oligometastatic Prostate Cancer: A Meta-Analysis. World Journal of Surgical Oncology, 19, 160. https://doi.org/10.1186/s12957-021-02265-8
|
[19]
|
Fossati, N., Trinh, Q.D., Sammon, J., et al. (2015) Identi-fying Optimal Candidates for Local Treatment of the Primary Tumor among Patients Diagnosed with Metastatic Prostate Cancer: A SEER-Based Study. European Urology, 67, 3-6.
https://doi.org/10.1016/j.eururo.2014.08.056
|
[20]
|
Satkunasivam, R., Kim, A.E., Desai, M., et al. (2015) Radical Prostatectomy or External Beam Radiation Therapy vs No Local Therapy for Survival Benefit in Metastatic Prostate Cancer: A SEER-Medicare Analysis. Journal of Urology, 194, 378-385. https://doi.org/10.1016/j.juro.2015.02.084
|
[21]
|
Löppenberg, B., Dalela, D., Karabon, P., et al. (2017) The Impact of Local Treatment on Overall Survival in Patients with Metastatic Prostate Cancer on Diagnosis: A National Cancer Data Base Analysis. European Urology, 72, 14-19.
https://doi.org/10.1016/j.eururo.2016.04.031
|
[22]
|
Gratzke, C., Engel, J. and Stief, C.G. (2014) Role of Radical Prostatectomy in Metastatic Prostate Cancer: Data from the Munich Cancer Registry. European Urology, 66, 602-603. https://doi.org/10.1016/j.eururo.2014.04.009
|
[23]
|
Lumen, N., De Bleser, E., Buelens, S., et al. (2021) The Role of Cytoreductive Radical Prostatectomy in the Treatment of Newly Diagnosed Low-Volume Metastatic Prostate Cancer. Results from the Local Treatment of Metastatic Prostate Cancer (LoMP) Registry. European Urology Open Science, 29, 68-76. https://doi.org/10.1016/j.euros.2021.05.006
|
[24]
|
Sweeney, C.J., Chen, Y.H., Carducci, M., et al. (2015) Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer. The New England Journal of Medicine, 373, 737-746. https://doi.org/10.1056/NEJMoa1503747
|
[25]
|
Babst, C., Amiel, T., Maurer, T., et al. (2022) Cytoreductive Radical Prostatectomy after Chemohormonal Therapy in Patients with Primary Metastatic Prostate Cancer. Asian Journal of Urology, 9, 69-74.
https://doi.org/10.1016/j.ajur.2021.04.003
|
[26]
|
Pompe, R.S., Tilki, D., Preisser, F., et al. (2018) Survival Benefit of Local versus No Local Treatment for Metastatic Prostate Cancer-Impact of Baseline PSA and Metastatic Substages. Prostate, 78, 753-757.
https://doi.org/10.1002/pros.23519
|
[27]
|
Liu, S., Wang, X.Y., Huang, T.B., et al. (2020) Effect on Survival of Local Treatment in Patients with Low Prostate-Specific Antigen, High Gleason Score Prostate Cancer: A Population-Based Propensity Score-Matched Analysis. Annals of Palliative Medicine, 9, 1708-1717. https://doi.org/10.21037/apm-19-414
|
[28]
|
Heidenreich, A., Pfister, D. and Porres, D. (2015) Cytoreductive Radical Prostatectomy in Patients with Prostate Cancer and Low Volume Skeletal Metastases: Results of a Feasibility and Case-Control Study. Journal of Urology, 193, 832-838. https://doi.org/10.1016/j.juro.2014.09.089
|
[29]
|
Gandaglia, G., Fossati, N., Stabile, A., et al. (2017) Radical Prostatectomy in Men with Oligometastatic Prostate Cancer: Results of a Single-Institution Series with Long-Term Follow-Up. European Urology, 72, 289-292.
https://doi.org/10.1016/j.eururo.2016.08.040
|
[30]
|
Yaxley, J.W., Coughlin, G.D., Chambers, S.K., et al. (2016) Robot-Assisted Laparoscopic Prostatectomy versus Open Radical Retropubic Prostatectomy: Early Outcomes from a Randomised Controlled Phase 3 Study [Published Correction Appears in Lancet. 2017 Apr 8, 389(10077): e5]. The Lancet, 388, 1057-1066.
https://doi.org/10.1016/S0140-6736(16)30592-X
|
[31]
|
Basiri, A., de la Rosette, J.J., Tabatabaei, S., Woo, H.H., Laguna, M.P. and Shemshaki, H. (2018) Comparison of Retropubic, Laparoscopic and Robotic Radical Prostatectomy: Who Is the Winner? World Journal of Urology, 36, 609-621. https://doi.org/10.1007/s00345-018-2174-1
|
[32]
|
Carbonara, U., Srinath, M., Crocerossa, F., et al. (2021) Ro-bot-Assisted Radical Prostatectomy versus Standard Laparoscopic Radical Prostatectomy: An Evidence-Based Analysis of Comparative Outcomes. World Journal of Urology, 39, 3721-3732. https://doi.org/10.1007/s00345-021-03687-5
|
[33]
|
Stolzenburg, J.U., Holze, S., Neuhaus, P., et al. (2021) Robot-ic-Assisted Versus Laparoscopic Surgery: Outcomes from the First Multicentre, Randomised, Patient-Blinded Controlled Trial in Radical Prostatectomy (LAP-01). European Urology, 79, 750-759. https://doi.org/10.1016/j.eururo.2021.01.030
|
[34]
|
Wagaskar, V.G., Mittal, A., Sobotka, S., et al. (2021) Hood Technique for Robotic Radical Prostatectomy-Preserving Periurethral Anatomical Structures in the Space of Retzius and Sparing the Pouch of Douglas, Enabling Early Return of Continence without Compromising Surgical Margin Rates. European Urology, 80, 213-221.
https://doi.org/10.1016/j.eururo.2020.09.044
|
[35]
|
Mazzone, E., Preisser, F., Nazzani, S., et al. (2019) The Effect of Lymph Node Dissection in Metastatic Prostate Cancer Patients Treated with Radical Prostatectomy: A Contemporary Analysis of Survival and Early Postoperative Outcomes. European Urology Oncology, 2, 541-548. https://doi.org/10.1016/j.euo.2018.10.010
|
[36]
|
Lestingi, J.F.P., Guglielmetti, G.B., Trinh, Q.D., et al. (2021) Ex-tended versus Limited Pelvic Lymph Node Dissection during Radical Prostatectomy for Intermediate- and High-Risk Prostate Cancer: Early Oncological Outcomes from a Randomized Phase 3 Trial. European Urology, 79, 595-604. https://doi.org/10.1016/j.eururo.2020.11.040
|
[37]
|
Qu, M., Zhu, F., Chen, H., et al. (2019) Palliative Transurethral Resection of the Prostate in Patients with Metastatic Prostate Cancer: A Prospective Study of 188 Patients. Journal of Endourology, 33, 570-575.
https://doi.org/10.1089/end.2019.0108
|
[38]
|
Qin, X.J., Ma, C.G., Ye, D.W., et al. (2012) Tumor Cytoreduction Results in Better Response to Androgen Ablation—A Preliminary Report of Palliative Transurethral Resection of the Prostate in Metastatic Hormone Sensitive Prostate Cancer. Urologic Oncology, 30, 145-149. https://doi.org/10.1016/j.urolonc.2010.02.010
|
[39]
|
Rom, M., Waldert, M., Schatzl, G., Swietek, N., Shariat, S.F. and Klatte, T. (2014) Bladder Outlet Obstruction (BOO) in Men with Castration-Resistant Prostate Cancer. BJU Inter-national, 114, 62-66. https://doi.org/10.1111/bju.12438
|
[40]
|
Seo, H.J., Lee, N.R., Son, S.K., Kim, D.K., Rha, K.H. and Lee, S.H. (2016) Comparison of Robot-Assisted Radical Prostatectomy and Open Radical Prostatectomy Outcomes: A Systematic Review and Meta-Analysis. Yonsei Medical Journal, 57, 1165-1177. https://doi.org/10.3349/ymj.2016.57.5.1165
|
[41]
|
Lantz, A., Bock, D., Akre, O., et al. (2021) Functional and On-cological Outcomes after Open versus Robot-Assisted Laparoscopic Radical Prostatectomy for Localised Prostate Cancer: 8-Year Follow-Up. European Urology, 80, 650-660.
https://doi.org/10.1016/j.eururo.2021.07.025
|